Manfred J Stangl

Manfred J Stangl is a notable inventor based in Sauerlach, Germany. He has made significant contributions to the fields of medical detection and stem cell therapy. With a total of 2 patents, his work focuses on innovative methods for early detection of health issues and advanced treatment options.

Latest Patents

Stangl's latest patents include an in vitro method for the early detection of potential inflammation, particularly associated with transplant rejection, neurodegenerative disorders, or depression. This method involves determining the level of kynurenine in saliva, allowing for easy performance and early detection of potential health problems. Another significant patent involves CD34 stem cell-related methods and compositions. This invention provides novel stem cell-based methods for treating various conditions without the need for myeloablation in the subject being treated. The CD34 stem cells used can be genetically modified or not, depending on the disorder being addressed.

Career Highlights

Throughout his career, Stangl has worked with several companies, including Apceth GmbH & Co. KG and Salion GmbH. His innovative approaches have positioned him as a key figure in the development of medical technologies.

Collaborations

Stangl has collaborated with notable professionals in his field, including Ralf Huss and Matthias C Raggi. These partnerships have further enhanced his contributions to medical science.

Conclusion

Manfred J Stangl's work exemplifies the impact of innovation in healthcare, particularly through his patents that address critical medical challenges. His contributions continue to influence the fields of medical detection and stem cell therapy.

This text is generated by artificial intelligence and may not be accurate.